Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program.
Journal
Current opinion in oncology
ISSN: 1531-703X
Titre abrégé: Curr Opin Oncol
Pays: United States
ID NLM: 9007265
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
pubmed:
22
4
2021
medline:
28
8
2021
entrez:
21
4
2021
Statut:
ppublish
Résumé
The Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) is a bottom-up clinical network established in 2013 with the goal of improving the care and outcomes of patients with retroperitoneal sarcoma (RPS). Here, we review the knowledge produced by this collaborative effort and examine the future potential of this group. TARPSWG has produced retrospective studies focused on patients with primary and recurrent RPS allowing a better understanding of patient prognosis, treatment outcomes and tumor biology. The group has played a pivotal role in a phase III randomized STudy of preoperative RAdiotherapy plus Surgery versus surgery alone for patients with Retroperitoneal Sarcoma (STRASS) trial, favoring patient recruitment and trial completion. A prospective registry for patients with primary RPS populated by TARPSWG members is ongoing. TARPSWG has created consensus papers with recommendations regarding the management of patients with primary, recurrent and metastatic RPS that collated the views of representatives of sarcoma centers from Europe, North America, Asia and Australia. Since its inception, TARPSWG has become a leading network in the field of RPS. It has made a major contribution to the world of RPS research and cares allowing to overcome the limitations related to the rarity of the disease through collaboration.
Identifiants
pubmed: 33882525
doi: 10.1097/CCO.0000000000000746
pii: 00001622-202107000-00009
doi:
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
301-308Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Stiller CA, Trama A, Serraino D, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013; 49:684–695.
Callegaro D, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas. Expert Rev Anticancer Ther 2015; 15:553–567.
Trans-Atlantic RPS Working Group. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015; 22:256–263.
Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997; 15:2832–2839.
Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221:185–195.
Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228:355–365.
Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27:31–37.
Strauss DC. Patterns of recurrence in retroperitoneal liposarcomas: reflecting surgical approach or tumor biology? Ann Surg Oncol 2014; 21:2113–2116.
Mussi C, Colombo P, Bertuzzi A, et al. Retroperitoneal sarcoma: is it time to change the surgical policy? Ann Surg Oncol 2011; 18:2136–2142.
Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009; 27:24–30.
Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19:2981–2991.
Tsivian A, Lev-Chelouche D, Shtabsky A, et al. Aggressive resection of retroperitoneal sarcoma is superior to simple excision: an animal study using a novel model for retroperitoneal sarcoma. J Surg Oncol 2002; 81:144–147.
Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol 2012; 23:1067–1073.
Pollock RE. Extended surgery for retroperitoneal sarcoma: too much surgery for some and not enough for others? Con Oncol 2013; 27:641–642.
Gronchi A. Extended surgery for retroperitoneal sarcoma: the key to maximizing the potential for cure and survival. Pro Oncol 2013; 27:640–642.
Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multiinstitutional collaborative RPS Working Group. Ann Surg 2016; 263:1002–1009.
Bonvalot S, Gronchi A, Le Péchoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2020; 21:1366–1377.
Villano AM, Zeymo A, Chan KS, et al. Identifying the minimum volume threshold for retroperitoneal soft tissue sarcoma resection: merging national data with consensus expert opinion. J Am Coll Surg 2020; 230:151–160. e2.
MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the Transatlantic RPS Working Group. Ann Surg 2018; 267:959–964.
Tseng WW, Tsao-Wei DD, Callegaro D, et al. Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma. Eur J Surg Oncol 2018; 44:810–815.
Haas RLM, Bonvalot S, Miceli R, et al. Radiotherapy for retroperitoneal liposarcoma: a report from the Transatlantic Retroperitoneal Sarcoma Working Group. Cancer 2019; 125:1290–1300.
Tseng WW, Barretta F, Conti L, et al. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: a multiinstitutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Cancer 2021; 127:729–738.
MacNeill AJ, Miceli R, Strauss DC, et al. Postrelapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group. Cancer 2017; 123:1971–1978.
Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 2013; 31:1649–1655.
Raut CP, Miceli R, Strauss DC, et al. External validation of a multiinstitutional retroperitoneal sarcoma nomogram. Cancer 2016; 122:1417–1424.
Raut CP, Callegaro D, Miceli R, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res 2019; 25:2664–2671.
DIGITAL FOREST srl. Applestore: https://geo.itunes.apple.com/us/app/sarculator/id1052119173?mt=8 Google Play: https://play.google.com/store/apps/details?id=it.digitalforest.sarculator Sarculator November 13, 2015.
van Houdt WJ, Fiore M, Barretta F, et al. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: a study from TARPSWG. Cancer 2020; 126:4917–4925.
Nessim C, Raut CP, Callegaro D, et al. Postoperative morbidity after resection of recurrent retroperitoneal sarcoma: a report from the Transatlantic Australasian RPS Working Group (TARPSWG). Ann Surg Oncol 2021; doi: 10.1245/s10434-020-09445-y. Online ahead of print.
doi: 10.1245/s10434-020-09445-y.
Raut CP, Strauss D, Haas R, et al. Why primary retroperitoneal sarcoma patients undergoing treatment at STRASS institutions did not enroll in STRASS: the STREXIT study from EORTC STBSG and TARPSWG. Connective Tissue Oncology Society 2018 Annual Meeting November 14–17, 2018, Rome (Italy).
Callegaro D, Raut CP, Ajayi T, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: trial (STRASS) vs off-trial (STREXIT) results. Connective Tissue Oncology Society 2019 Virtual Annual Meeting November 18–21, 2020.
Callegaro D, Raut CP, Ng D, et al. Has the outcome for patients who undergo resection of primary retroperitoneal sarcoma changed over time? A study of time trends during the past 15 years. Ann Surg Oncol 2021; 28:1700–1709.
Callegaro D, Barretta F, Swallow C, et al. Longitudinal prognostication in patients with primary retroperitoneal sarcoma treated with surgery: development and external validation of a dynamic prognostic nomogram. Connective Tissue Oncology Society 2019 Annual Meeting November 13–16, 2019, Tokyo (Japan).
Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Oncol 2018; 29:857–871.
Trans-Atlantic RPS Working Group. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2016; 23:3531–3540.
Swallow C, Strauss D, Bonvalot S, et al. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Ann Surg Oncol 2021; in press.
Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Intercontinental collaborative experience with abdominal, retroperitoneal and pelvic schwannomas. Br J Surg 2020; 107:452–463.
Tattersall HL, Hodson J, Cardona K, et al. Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). J Surg Oncol 2021; 123:1057–1066.
van Houdt WJ, Raut CP, Bonvalot S, et al. New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. Curr Opin Oncol 2019; 31:310–316.
Al-Sukhni E, van Houdt WJ, Burtenshaw SM, et al. Virtual biobanking for retroperitoneal sarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Initiative. Ann Surg Oncol 2020; 27:3573–3576.